APA (7th ed.) Citation

Heerspink, H. J. L., Stack, A. G., Terkeltaub, R., Greene, T. A., Inker, L. A., Bjursell, M., . . . Perkovic, V. (2022). Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia. Nephrology Dialysis Transplantation, 37(8), 1461. https://doi.org/10.1093/ndt/gfab237

Chicago Style (17th ed.) Citation

Heerspink, Hiddo J L., et al. "Rationale, Design, Demographics and Baseline Characteristics of the Randomized, Controlled, Phase 2b SAPPHIRE Study of Verinurad Plus Allopurinol in Patients with Chronic Kidney Disease and Hyperuricaemia." Nephrology Dialysis Transplantation 37, no. 8 (2022): 1461. https://doi.org/10.1093/ndt/gfab237.

MLA (9th ed.) Citation

Heerspink, Hiddo J L., et al. "Rationale, Design, Demographics and Baseline Characteristics of the Randomized, Controlled, Phase 2b SAPPHIRE Study of Verinurad Plus Allopurinol in Patients with Chronic Kidney Disease and Hyperuricaemia." Nephrology Dialysis Transplantation, vol. 37, no. 8, 2022, p. 1461, https://doi.org/10.1093/ndt/gfab237.